✦ LIBER ✦

Cost/Benefit Analysis of First Line Chronic Lymphocytic Leukemia (CLL) Treatments in Mexico

✍ Scribed by Wehler, E.; Leyva, V.; Bertwistle, D.; Munakata, J.; Valencia, A.; Hernandez, A.; de la Torre, L.; Gonzalez, L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chronic Lymphocytic Leukemia (CLL): Firs

✍ Hallek, M. 📂 Article 📅 2005 🏛 American Society of Hematology 🌐 English ⚖ 71 KB

The Cost-Effectiveness of Bendamustine V

✍ Bertwistle, D.; Munakata, J.; Wehler, E.; Leyva, V.; Valencia, A.; Hernandez, A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Cost-Effectiveness of Bendamustine Versu

✍ Bertwistle, D.; Munakata, J.; Wehler, E; Leyva, V.; Ariza, J.G.; Zambrano, C.; G 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Making Advances in First-Line Chronic Ly

✍ Wierda, W. G. 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 60 KB

First-Line Treatment in Chronic Lymphocy

✍ Nabhan, Chadi 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 111 KB

Vitamin D insufficiency predicts time to

✍ Stefano Molica; Giovanna Digiesi; Anna Antenucci; Luciano Levato; Rosanna Mirabe 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 552 KB